JamesE.HartleMD

PubMed

• 4 citations
  Need for payer-provider partnerships in addressing social determinants of health
  Joseph T. Kannarkat, James E. Hartle, Natasha Parekh> ;Journal of Managed Care & Specialty Pharmacy. 2021 May 31
• 132 citations
  Bariatric surgery is associated with improvement in kidney outcomes.
  Alex R. Chang, Yuan Chen, G. Craig Wood, H. Lester Kirchner, Meredith Lewis, Holly Kramer, James E. Hartle, David J. Carey, Lawrence J. Appel, Morgan E. Grams> ;Kidney International. 2016 Jul 1
• 10 citations
  Bisphosphonates and mortality in women with CKD and the presence or absence of cardiovascular disease.
  Robert M. Perkins, H. Lester Kirchner, Kunihiro Matsushita, Ion D. Bucaloiu, Evan R. Norfolk, James E. Hartle> ;Clinical Journal of the American Society of Nephrology. 2014 May 7
• 16 citations
  Readmission after hospitalization for heart failure among patients with chronic kidney disease: a prediction model.
  Robert M. Perkins, Amir Rahman, Ion D. Bucaloiu, Evan R. Norfolk, William DiFilippo, James E. Hartle, H. Lester Kirchner> ;Clinical Nephrology. 2013 Dec 1
• 11 citations
  Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.
  Robert M. Perkins, H. Lester Kirchner, James E. Hartle, Ion D. Bucaloiu> ;Clinical Nephrology. 2013 Oct 1
• 6 citations
  Nephrology Care in a Fully Integrated Care Model: Lessons from the Geisinger Health System
  Evan R. Norfolk, James E. Hartle> ;Clinical Journal of the American Society of Nephrology. 2013 Apr 5
• 396 citations
  Increased risk of death and de novo chronic kidney disease following reversible acute kidney injury
  Ion D. Bucaloiu, H. Lester Kirchner, Evan R. Norfolk, James E. Hartle, Robert M. Perkins> ;Kidney International. 2012 Mar 1
• 29 citations
  Bisphosphonate Therapy, Death, and Cardiovascular Events Among Female Patients With CKD: A Retrospective Cohort Study
  James E. Hartle, Xiaoqin Tang, H. Lester Kirchner, Ion D. Bucaloiu, Jennifer Sartorius, Zhanna V. Pogrebnaya, Gwendolyn A. Akers, Guillermo Carnero, Robert M. Perkins> ;American Journal of Kidney Diseases. 2012 May 1
• 6 citations
  Fat-free weight prediction in morbidly obese females
  Ion D. Bucaloiu, G. Craig Wood, Evan R. Norfolk, James E. Hartle, Robert M. Perkins> ;International Journal of Nephrology and Renovascular Disease. 2011 Nov 21
• 105 citations
  GFR decline and mortality risk among patients with chronic kidney disease.
  Robert M. Perkins, Ion D. Bucaloiu, H. Lester Kirchner, Nasrin Ashouian, James E. Hartle, Taher Yahya> ;Clinical Journal of the American Society of Nephrology. 2011 Aug 1
• 55 citations
  A prospective study of risk factors for nephrolithiasis after Roux-en-Y gastric bypass surgery.
  Alyssa M. Park, Douglas W. Storm, Brant R. Fulmer, G. Craig Wood, James E. Hartle> ;The Journal of Urology. 2009 Nov 1
• 18 citations
  Outpatient erythropoietin administered through a protocol-driven, pharmacist-managed program may produce significant patient and economic benefits.
  Ion D. Bucaloiu, Gwendolyn A. Akers, Maria C Bermudez, Roshan Mainali, Barbara L Brown, Stephanie S Roberts, James E. Hartle> ;Managed Care Interface. 2007 Jun 1
• 2 citations
  Chronic active thrombotic microangiopathy in native and transplanted kidneys.
  Ping L. Zhang, Jeffery W. Prichard, Fan Lin, Michael F. Shultz, Sayeed K. Malek, John H. Shaw, James E. Hartle> ;Annals of Clinical and Laboratory Science. 2006 Jun 20
• 50 citations
  Campath-1H induction and the incidence of infectious complications in adult renal transplantation.
  Sayeed K. Malek, Melissa A Obmann, Robert Gotoff, Michael A. Foltzer, James E. Hartle, Santosh Potdar> ;Transplantation. 2006 Jan 15
• 2 citations
  IgM Type of Membranous Glomerulopathy in a Diabetic Patient
  Ping L. Zhang, Taher Yahya, Jeffrey W. Prichard, John H. Shaw, James E. Hartle, Fan Lin, Michael S. Schwartzman> ;Annals of Clinical and Laboratory Science. 2005 Apr 1
• 23 citations
  Acute cellular rejection predominated by monocytes is a severe form of rejection in human renal recipients with or without Campath-1H (alemtuzumab) induction therapy.
  Ping L. Zhang, Sayeed K. Malek, Jeffery W. Prichard, Fan Lin, Taher Yahya, Michael S. Schwartzman, Ruth P. Latsha, Evan R. Norfolk, Thomas M. Blasick, Mingyue Lun, Rob...> ;American Journal of Transplantation. 2005 Mar 1
• 6 citations
  Monocyte-mediated acute renal rejection after combined treatment with preoperative Campath-1H (alemtuzumab) and postoperative immunosuppression.
  Ping L. Zhang, Sayeed K. Malek, Jeffery W. Prichard, Fan Lin, Taher Yahya, Michael S. Schwartzman, Ruth P. Latsha, Marybess Skaletsky, Evan R. Norfolk, Robert E. Brown...> ;Annals of Clinical and Laboratory Science. 2004 Apr 1
• 24 citations
  Preoperative dobutamine stress echocardiography versus cardiac arteriography for risk assessment prior to renal transplantation
  John C. West, D. A. Napoliello, J. M. Costello, L. A. Nassef, R. J. Butcher, James E. Hartle, T. R. McConnell, J. W. Finley, S. E. Kelley, S. Chao, R. Latsha> ;Transplant International. 2000 Jan 1
• Topical mupirocin and catheter-related bacteremia.
  Hartle, J. E., Norfolk, E., Schwartzman, M., Yahya, T.> ;Clin Infect Dis. 2004 Jun 1
• Renal cortical thickness as a predictor of renal function and blood pressure status post renal artery stenting.
  Padigala, K. K., Hartle, J. E., Kirchner, H. L., Schultz, M. F.> ;Angiology.
• Transplantation and 6-month follow-up of renal transplantation from a donor with systemic lupus erythematosus and lupus nephritis.
  Schwartzman, M. S., Zhang, P. L., Potdar, S., Malek, S. K., Norfolk, E. R., Hartle, J. E., Weicker, C. A., Yahya, T. M., Shaw, J. H.> ;Am J Transplant. 2005 Jul
• Role of ultrasound screening for gallbladder disease in pretransplant patients.
  Meka, M., Potdar, S., Benotti, P., Hartle, J. E., Senkowski, C.> ;Am Surg. 2008 Sep 01
• Join now to see all